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Abstract: The centrosome is the main microtubule-organizing center of animal cells, which plays key roles in critical cellular processes
ranging from cell division to cellular signaling. Accordingly, defects in the structure and function of centrosomes cause various human
diseases such as cancer and primary microcephaly. To elucidate the molecular defects underlying these diseases, the biogenesis and
functions of the centrosomes have to be fully understood. An essential step towards addressing these questions is the identification
and functional dissection of the full repertoire of centrosome proteins. Here, we used high-resolution imaging and showed that the
microtubule plus-end tracking protein SLAIN2 localizes to the pericentriolar material at the proximal end of centrioles. To gain insight
into its cellular functions and mechanisms, we applied in vivo proximity-dependent biotin identification to SLAIN2 and generated its
proximity interaction map. Gene ontology analysis of the SLAIN2 interactome revealed extensive interactions with centriole duplication,
ciliogenesis, and microtubule-associated proteins, including previously characterized and uncharacterized interactions. Collectively,
our results define SLAIN2 as a component of pericentriolar material and provide an important resource for future studies aimed at
elucidating SLAIN2 functions at the centrosome.
Key words: SLAIN2, microtubules, proximity mapping

1. Introduction
The centrosome is the main microtubule-organizing
center of animal cells, which play skey roles in critical
cellular processes ranging from cell division to cellular
signaling (Chavali et al., 2014). The centrosome consists
of two cylindrical microtubule-based structures termed
centrioles and associated pericentriolar material, which
supports microtubule nucleation, polymerization, and
stability (Bettencourt-Dias and Glover, 2007; Luders
and Stearns, 2007; Nigg and Raff, 2009). In cycling
cells, centrosomes organize the interphase microtubule
network, which is required for vesicular trafficking, cell
migration and cell shape (Luders and Stearns, 2007). In
dividing cells, centrosomes form the mitotic spindle, which
mediates equal segregation of genetic material to daughter
cells (Nigg and Raff, 2009). In some cycling cells and most
quiescent noncycling cells, one of the centrioles forms
the basal body that nucleates the microtubule axoneme
of the primary cilium. The primary cilium is a nonmotile
sensory organelle, which serves as the nexus for growth
factor and mechano-sensing signaling pathways important
in development and tissue homeostasis (Malicki and
Johnson, 2017; Mirvis et al., 2018). In addition, specialized

multiciliated epithelial cells such as trachea and fallopian
tube have many motile cilia on their surface that mediates
liquid movement, and sperm cells have a single motile
cilium that is required for their motility.
Centrosome and cilium dysfunction are associated
with a variety of human diseases including cancer and
ciliopathies (Hildebrandt et al., 2011; Nigg et al., 2014). The
association between centrosomal abnormalities and cancer
was first observed in the late 1800s; indeed it was one of
the first cell biological defects noted in cancer cells (Boveri
2008). The most obvious defect is that cancer cells often
have supernumerary centrosomes, which is associated
with genome instability due to chromosome attachment
errors (Bettencourt-Dias et al., 2011). Moreover, recent
studies demonstrated that extra centrosomes disrupts
ciliary signaling and epithelial organization through
formation of extra cilia and promote invasive behavior
through activation of Rac-mediated actin polymerization
(Nigg and Holland, 2018). Given their sensory roles in
developmental signaling pathways, defects in ciliogenesis
and cilium function results in genetic diseases called
ciliopathies, which are characterized by a broad spectrum
of anomalies in multiple organ systems (Hildebrandt et al.,
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2011; Braun and Hildebrandt, 2017). To better understand
these disease connections and develop new diagnostic and
therapeutic approaches, the mechanisms underlying the
biogenesis and functions of centrosomes and cilia have to
be fully understood. An essential step towards addressing
this question is the identification of the full repertoire of
proteins that localize to centrosomes and cilia and the
subsequent functional and biochemical dissection of these
proteins.
Over the years, a combination of proteomic,
transcriptomic, bioinformatics studies, and genetic screens
has identified many proteins that localize to the centrosome.
The proteomic analysis of the human interphase
centrosome by combining centrosome purifications with
protein correlation profiling by Andersen 2003 (Andersen
et al., 2003) identified 108 proteins; the genome-wide RNA
interference by Dobellaere (2008) identified 32 proteins, the
proteomic profiling of the mitotic Drosophila centrosome
by Muller (2005) identified 251 proteins and the proteomic
analysis of the mammalian sperm centrioles by FiratKaralar (2014) identified 364 proteins (Dobbelaere et al.,
2003; Muller et al., 2005; Firat-Karalar et al., 2014). A key
advance in expanding these proteomic lists and probing
the interactions among these proteins is the application
of the proximity-labeling approaches to the centrosome
(Firat-Karalar et al., 2014; Firat-Karalar and Stearns 2015).
BioID proximity-labeling makes use of promiscuous biotin
ligases to identify the proximity partners within 10 nm
diameter of the proteins of interest (Roux et al., 2013). The
proximity mapping of 58 centrosome proteins generated
a topology protein interaction network comprising more
than 7000 interactions (Gupta et al., 2015). The advantage
of the proximity labeling approaches is their ability
to identify transient and insoluble interactions of bait
proteins, which are not accessed before using traditional
pulldowns (Lambert et al., 2014). Although these studies
together revealed a nearly complete centrosome proteome,
the functions and mechanisms of many of centrosome
proteins still remain poorly understood. Among these
proteins, we chose SLAIN2 for further characterization
due to its reported functions in microtubule dynamics and
mesenchymal cell invasion as well as its link to colorectal
cancer (van der Vaart et al., 2011; van der Vaart et al., 2012;
Bouchet et al., 2016; Zhuang et al., 2019).
SLAIN2 was first identified in the purified centrosome
fractions of mammalian lymphoblasts in a highthroughput mass spectrometry study and subsequently
GFP-SLAIN2 was shown to localize to centrosomes
(Jakobsen et al., 2013). SLAIN2 was later identified as
a new microtubule plus-end tracking protein (+TIP)
that forms a complex with end-binding proteins (EBs),
cytoplasmic linker proteins (CLIPs) and ch-TOG, and
promotes processive microtubule growth in interphase
cells (van der Vaart et al., 2011). Moreover, SLAIN2 and
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CLASP1 together suppress catastrophes and are essential
for mesenchymal cell invasion in 3D culture and in a
mouse cancer model (Bouchet et al., 2016). Supporting
its link to cancer, the long noncoding RNA MALAT1 was
shown to regulate miR-106b-5p expression to promote
the invasion and metastasis of colorectal cancer by
enhancing the mobility of microtubules (Zhuang et al.,
2019). Although these studies provided new insight into
the control of microtubule plus end dynamics in cells and
in cancer, the centrosomal functions and mechanisms of
SLAIN2 remain unknown. Here, we used high-resolution
microscopy, BioID proximity-mapping, and gene ontology
analysis to determine the cellular localization of SLAIN2
and its interactions. The results of our study identified
SLAIN2 as a proximal component of centrosomes and
revealed extensive interactions with a wide range of
centrosome proteins including the ones implicated in
centriole duplication and cilium assembly. Collectively,
these results provide new insight into the centrosomal
functions of SLAIN2 and the molecular defects underlying
cancer associated with deregulation of SLAIN2.
2. Materials and methods
2.1. Plasmids
Full-length cDNA of SLAIN2 (GenBank Accession.
NM_020486.1) was obtained from DF/HCC DNA
Resource Core (Harvard Medical School, MA). pCMVt7mh-Cep152 (GenBank Accession no. NM_001194998)
was previously described and used for expression of
myc-Cep152 (Hatch et al., 2010). The ORF of SLAIN2
was amplified by PCR and cloned into pDONR221 using
Gateway cloning (Invitrogen). Subsequent Gateway
recombination reactions using pLVPT2-V5-BirA*
provided by Christian Hoerner (Stanford University,
Stanford, CA) was used to generate V5-BirA*-SLAIN2. All
constructs were verified by Sanger sequencing.
2.2. Cell culture and transfection
Human bone osteosarcoma (U2OS, ATCC, HTB-96) and
human embryonic kidney (HEK293T, ATCC, CRL-3216)
cells were cultured in DMEM supplemented with 10%
FBS and 1% penicillin/streptomycin at 37 °C and 5% CO2.
U2OS and HEK293T cells were tested for mycoplasma
contamination by MycoAlert Mycoplasma Detection Kit
(Lonza). For microtubule depolymerizaton experiments,
cells were seeded on glass coverslips in 24-well plates
and treated with 10 μg/mL nocodazole (Sigma-Aldrich)
diluted from 10 mM stock solution in DMSO for 1 h at
37 °C. DMSO was diluted at 1:1000 and used as vehicle
control. U2OS cells were transfected with the plasmids
using Lipofectamine 2000 according to the manufacturer’s
instructions (Invitrogen). HEK293T cells were transfected
with the plasmids using 1 μg/μl polyethylenimine, MW 25
kDa (PEI, Plysciences, Warrington, PA).
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2.3. Lentivirus production and cell transduction
HIV-derived recombinant lentivirus expressing V5-BirA*
or V5-BirA*-SLAIN2 were generated using the pLVPT-V5BirA* and pLVPT-V5-BirA*-SLAIN2 lentiviral transfer
vectors, respectively. HEK293T cells were grown to 70–
80% confluency and cotransfected with the pCMVDR8.74
packaging vector, pMD2.VSVG envelope vector (Dull
et al., 1998) and transfer vectors using 1 µg/µL PEI.
Medium was changed 6 h posttransfection and lentiviral
supernatant lentiviral supernatant was harvested after 48 h
and passed through a 0.45-µm filter. The viral supernatant
was titered by transducing cells with varying volumes of
virus. For transduction, 2 × 104 U2OS cells were seeded
on 12-well tissue culture plates and transduced with
lentivirus with an approximate multiplicity of infection
(MOI) of 1 in 2 consecutive days. Transduction efficiency
was determined by immunofluorescence experiments.
U2OS and HEK293T clones stably expressing V5-BirA*SLAIN2 were expanded and used in immunofluorescence
and proximity labeling experiments.
2.4. Streptavidin pulldown experiments
HEK293T stably expressing V5-BirA*-SLAIN2 or V5BirA* were grown in 5 × 15 cm dishes. At 70–80%
confluency, cells were incubated with complete medium
supplemented with 50 μM biotin. After 18 h of incubation
with biotin, the cells were scraped and lysed at 25 °C in
lysis buffer (50 mM Tris, pH 7.4, 500 mM NaCI, 0.4%
SDS, 5 mM EDTA, 1 mM DTT, 2% Triton X-100, protease
inhibitors) and sonicated. After adding an equal volume of
4 °C 50 mM Tris (pH 7.4) to the extract, insoluble material
was pelleted by centrifugation at 14,000 rpm for 20 min.
The soluble supernatants were incubated with Streptavidin
agarose beads (Invitrogen) overnight at 4 °C, followed by
washing twice in wash buffer 1 (2% SDS in dH2O), once
with wash buffer 2 (0.2% deoxycholate, 1% Triton X-100,
500 mM NaCI, 1 mM EDTA, and 50 mM Hepes, pH 7.5),
once with wash buffer 3 (250 mM LiCI, 0.5% NP-40, 0.5%
deoxycholate, 1% Triton X-100, 500 mM NaCI, 1 mM
EDTA and 10 mM Tris, pH 8.1) and twice with wash buffer
4 (50 mM Tris, pH 7.4, and 50 mM NaCI). After validation
of successful pulldown by Western blotting using 10% of
the sample, 90% of the remaining sample was washed twice
in 50 mM NH4HCO3 and analyzed by mass spectrometry.
2.5. Mass spectrometry experiments and data analysis
Biotinylated proteins were digested following an on-bead
tryptic digestion protocol and peptides were analyzed
by online C18 nanoflow reversed-phase nano liquid
chromatography (Dionex Ultimate 3000 RS LC, Thermo
Scientific) combined with orbitrap mass spectrometer
(Q Exactive Orbitrap, Thermo Scientific). Samples were
separated in an in-house packed 75 μm i.d. × 23 cm C18
column (Reprosil-Gold C18, 3 μm, 200 Å, Dr. Maisch)
using 75-min linear gradients from 5–25%, 25–40%,

40–95% acetonitrile in 0.1% formic acid with 300 nL/min
flow for 90 min. The scan sequence began with an MS1
spectrum (Orbitrap analysis; resolution 70,000; mass
range 400–1500 m/z; automatic gain control (AGC) target
1e6; maximum injection time 32 ms). Up to 15 of the most
intense ions per cycle were fragmented and analyzed in
the orbitrap with Data Dependent Acquisition (DDA).
MS2 analysis consisted of collision-induced dissociation
(higher-energy collisional dissociation (HCD)) (resolution
17,500; AGC 1e6; normalized collision energy (NCE) 26;
maximum injection time 85 ms). The isolation window for
MS/MS was 2.0 m/z.
Raw files were processed with Thermo Proteome
Discoverer 1.4 .Carbamidomethylation of cysteine was
used as fixed modification and acetylation (protein
N-termini) and oxidation of methionine were used as
variable modifications. Maximal two missed cleavages
were allowed for the tryptic peptides. The precursor mass
tolerance was set to 10 ppm and both peptide and protein
false discovery rates (FDRs) were set to 0.01. The database
search was performed against the human Uniprot database
(release 2016). The database also had sequence for E. coli
BirA-R118G appended to it.
Data for SLAIN2 BioID experiments were derived
from three biological replicates. Control data were derived
from 7 independent experiments of HEK293T cells stably
expressing V5-BirA*. To compare data across different runs,
the normalization of spectral counts (Zybailov et al., 2006)
was applied with the exception of dividing normalized
spectral counts to protein length. Briefly, spectral count for
each protein was normalized against the sum of spectral
counts in a particular run. Normalized spectral factors
for each protein were multiplied by 100 for presentation
purposes. To define the nonspecific interactions, the
ration of spectral abundance factor of each protein was
divided to the one in control if protein was identified in
control datasets. A protein was considered a contaminant
if the ratio was greater than 2. Additionally, proteins that
were estimated as mass spectrometry contaminants by
the contaminant repository for affinity purification-mass
spectrometry data (Mellacheruvu et al., 2013) were filtered
out as contaminant proteins if they were identified in more
than 85 out of 411 experiments. Finally, we only accounted
for proteins that were identified in at least 2 out of three
independent experiments and that have a spectral count
greater than 4. The numbers presented in Figure 3 is
average spectral abundance factors of three independent
experiments. Interaction networks were visualized in
Cytoscape 3.7.1 (Shannon et al., 2003), and graphically
edited in Adobe Illustrator 24.0.1. Gene ontology (GO)
analysis were performed with the indicated proteins using
the EnrichR web server (Kuleshov et al., 2016)
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2.6. Antibodies
Anti-PCM1 antibody was generated and used
for immunofluorescence as previously described
(Firat-Karalar et al., 2014). Antibodies used for
immunofluorescence experiments were rabbit antiSLAIN2 (Proteintech, Cat#13908-1-AP) at 1:1000, mouse
anti-gamma-tubulin (GTU-88; T5326; Sigma-Aldrich)
at 1:4000, mouse anti alpha tubulin (Sigma, DM1A) at
1:1000, mouse anti-centrin 3 (Abnova; clone 3E6) at
1:750) and mouse anti-V5 (Thermo Scientific; R960-25)
at 1:500. AlexaFluor 488-, 568-, or 633-coupled secondary
antibodies (Life Technologies) were used at 1:2000. Nuclei
was stained with 4-,6-diamidino-2-phenylindole (DAPI)
at 1 µg/mL. Antibodies used for western blotting were
rabbit anti-SLAIN2 (Proteintech, Cat#13908-1-AP) at
1:1000 and anti-p38 (Santa Cruz Biotechnology) at 1:1000.
IRDye680- and IRDye 800-coupled secondary antibodies
were used at 1:10,000 for western blotting experiments
(LI-COR Biosciences).
2.7. Immunofluorescence and microscopy
Cells were grown on coverslips were washed two times with
PBS and fixed in ice cold methanol at –20 °C for 10 min.
After rehydration in PBS, cells were blocked with 3% BSA
(Capricorn Scientific, Cat. # BSA-1T) in PBS + 0.1% Triton
X-100 followed by incubation with primary antibodies in
blocking solution for 1 h at room temperature. Following
three washes with PBS, the cells were incubated with Alexacoupled secondary antibodies and DAPI. The cells were
washed three times with PBS and mounted using Mowiol
mounting medium containing N-propyl gallate (SigmaAldrich). Fluorescence images were acquired using a
HyVolution confocal scanning microscope equipped with
HC PL APO CS2 63× 1.4 NA oil objective with 0.3 µm
step size and 4 µm stack size in 1024 × 1024 pixel format.
The z-stacks were used to assemble maximum-intensity
projections. For higher resolution imaging of SLAIN2
at the centrosome, fluorescence signals were detected by
HyD detectors and processed with Huygens Essential
software (Scientific Volume Imaging). Image processing
was performed using ImageJ (National Institutes of Health,
Bethesda, MD).
2.8. Cell lysis and western blotting
Cell extracts were prepared by lysing cells in 50 mM Tris
(pH 7.6), 150 mM NaCI, 1% Triton X-100 and protease
inhibitors for 30 min at 4 °C followed by centrifugation
at 14,000 rpm for 15 min. The protein concentration of
lysates was determined with the Bradford solution (BioRad Laboratories, CA, USA) using bovine serum albumin
as a standard. For western blotting, cell extracts were
resolved on 10% acrylamide sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE) using
the Mini-Protean system (Bio-Rad Laboratories, CA,
USA) followed by transfer onto nitrocellulose membranes
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using the Mini Transblot wet transfer system (Bio-Rad
Laboratories, CA, USA). Membranes were incubated
in blocking solution (PBS+5% milk, 0.1%Tween-20)
for 1 h at room temperature, incubated with primary
antibodies overnight at 4 °C and washed three times with
PBS+0.1%Tween-20 (PBST). After secondary antibody
incubation for 1 h at room temperature and washing three
times with PBST, the blots were scanned using the LI-COR
Odyssey® scanner and software (LI-COR Biosciences) at
169 µm.
2.9. Statistical analysis
Statistical results, average, and standard deviation values
were computed and plotted by using Prism (GraphPad, La
Jolla, CA). Two-tailed t-tests and ANOVA were applied to
compare the statistical significance of the measurements.
3. Results
3.1. SLAIN2 localizes to the centrosome throughout the
cell cycle
To investigate the cellular functions and mechanisms of
SLAIN2 at the centrosome, we examined the localization
of endogenous SLAIN2 and a V5-SLAIN2 fusion protein
in human osteosarcoma U2OS cells, which are wellcharacterized for their centrosome biogenesis and ideal
for visualizing the microtubule network due to their
flat morphology. We determined endogenous SLAIN2
localization by staining cells with a rabbit polyclonal
antibody raised against the C-terminal 231-581 amino acid
fragment of SLAIN2 relative to staining for the centrosome
marker gamma-tubulin. The different cell cycle phases
were distinguished by the distinct staining of the nucleus.
SLAIN2 colocalized with gamma-tubulin at all cell cycle
stages, apparent as centrosome staining as one or two
proximate puncta next to the nucleus in interphase cells
and spindle pole staining from early prophase to telophase
in mitotic cells (Figure 1A). Analogous to endogenous
SLAIN2, V5-SLAIN2 colocalized with gamma-tubulin in
U2OS cells stably expressing the fusion protein (Figure
1B). Notably, V5-SLAIN2 also localized to the microtubule
ends high expressing cells (Figure 1B), which is consistent
with its reported characterization as microtubule plus-end
protein (van der Vaart et al., 2011). Of note, microtubule
tip localization was not apparent in U2OS cells
immunostained with anti-SLAIN2 antibody. Supporting
its specificity, anti-SLAIN2 antibody recognized a specific
band at the expected size of 581 amino acid isoform 1
(62.5 kDa) in U2OS and mouse inner medullary collecting
duct IMCD3 cell extracts by Western blotting (Figure 1C).
There was also an additional smaller band, which likely
represents a different SLAIN2 isoform.
Given the affinity of SLAIN2 to microtubules, we next
tested whether SLAIN2 localization to the centrosome
depends on microtubules or not. To this end, U2OS
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cells were treated with nocodazole to depolymerize
microtubules, which was confirmed by immunostaining
for alpha-tubulin. SLAIN2 localized to the centrosomes
in both cells treated with DMSO vehicle control and
nocodazole, suggesting that centrosomal localization of
a fraction of SLAIN2 at the centrosome is independent
of microtubules (Figure 1D). Collectively, these results

identify SLAIN2 as a bona fide centrosome protein
and suggest functions for SLAIN2 at the centrosome in
addition to its reported functions at the microtubule plus
ends.
3.2. SLAIN2 localizes to the proximal end of the centrioles
Centrosomes are composed of two centrioles and associated
pericentriolar material. Application of superresolution

Figure 1. SLAIN2 localizes to the centrosome. (A) Asynchronous U2OS cells were immunostained with antibodies against SLAIN2
(green) and gamma-tubulin (red), which marks the pericentriolar material. DNA was stained with DAPI. Representative images of
SLAIN2 localization at different stages of the cell cycle are shown. (B) V5-SLAIN2 fusion protein localizes to the centrosome in lowexpressing cells and to the centrosome and microtubules in high-expressing cells. U2OS heterogeneous pools stably expressing V5SLAIN2 were immunostained with antibodies against V5 and gamma-tubulin. (C) Immunoblots of human U2OS and mouse IMCD3
cell extracts with anti-SLAIN2 antibody and anti-p38 antibody, which was used a loading control. The expected size for full length
SLAIN2 is 62 kDa, which corresponds to the upper band. The lower band likely represents an isoform of SLAIN2. (D) SLAIN2 localizes
to the centrosome upon microtubule depolymerization. U2OS cells were treated with DMSO vehicle control or nocodazole for 1 h and
immunostained with antibodies against SLAIN2 and alpha-tubulin, which marks the centrosome. The yellow dashed boxes represent
the centrosomes used for zoomed insets. Scale bars represent 10 μm.
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microscopy approaches to centrosome proteins over the
years have revealed a highly regulated architecture for the
centrosome and distinct subcentrosomal domains were
associated with specific functions (Figure 2A) (Luders
2012). To gain insight into the centrosomal functions of
SLAIN2, we used high resolution imaging and defined the
spatial localization of SLAIN2 at the centrosome. To this
end, SLAIN2 was immunostained with the centriole distal
end marker Centrin 3 and the pericentriolar material
component Cep152 (Sonnen et al., 2012). SLAIN2 localized
to a resolvable ring at the proximal end of the centrioles in
both G0/G1 and S phase cells, which encompassed Cep152
staining at the pericentriolar material (Figures 2B and S1).

Confirming its proximal localization, SLAIN2 and centrin
signals did not overlap (Figure S1). These results identify
SLAIN2 as a component of the pericentriolar material
at the proximal end of centrioles and suggest functions
associated with this subdomain such as microtubule
dynamics, pericentriolar material organization, and/or
centriole duplication.
3.3. Gene ontology and STRING analysis of the SLAIN2
proximity interactome
BioID-based proximity labeling has proven to be a
powerful tool in defining interactions at the centrosome,
in particular the transient highly dynamic or insoluble
ones (Firat-Karalar and Stearns, 2015). To gain insight

Figure 2. SLAIN2 localizes to the proximal end of the centrioles at the pericentriolar material. (A) Schematic representation of different
subcentrosomal domains with their associated markers. Cross-section view of the proximal end of centrioles represents the localization
of SLAIN2 at the pericentriolar material relative to Cep152. (B) U2OS cells were transfected with myc-Cep152 expression construct,
fixed and stained for SLAIN2 (green), myc-Cep152 (pericentriolar material protein) (red) and centrin 3 (distal end of centrioles)
(magenta). DNA was stained with DAPI (blue). For high-resolution imaging, fluorescence signals were detected with HyD detectors
and processed with Hyvolution software. Representative images for SLAIN2 localization in G0/G1 phase and S phase cells (duplicated
centrioles) are shown. Scale bars represent 5 μm. Insets show 6X enlarged centrosomes.
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into the cellular functions of SLAIN2 in an unbiased
way, we identified proximity interactors of SLAIN2
using the BioID approach. Myc-BirA (R118G) (hereafter
BirA*) was fused to the N-terminus of SLAIN2 in a
lentiviral expression vector, which was used to generate
HEK293T cells stably expressing BirA*-SLAIN2. After 18
h of incubation of the cells with 50 µM biotin, we found
that BirA*-SLAIN2 localized to the centrosome and
induced biotinylation at the centrosome, as assessed by
streptavidin staining to detect biotinylated proteins and
the centrosome marker anti-gamma-tubulin (Figure 3A).
In addition to its localization at the centrosome, BirA*SLAIN2 also localized to and induced biotinylation at the
microtubules (Figure 3A). Of note, we note that V5 signal
of the ectopically expressed fusion protein was specific to
the microtubule plus ends, the biotinylation signal was
detected along microtubule filaments. This difference is
likely due to covalent biotinylation of the spatial proximity
of BirA* at the microtubules during 18 h of biotinylation.
Finally, in a small subset of cells, BirA*-SLAIN2 induced
biotinylation of granules around the centrosome, which
likely are the centriolar satellites (Figure 3A). These results
confirm correct localization of the V5-BirA*-SLAIN2
fusion protein at the centrosome and microtubules.
To identify proximity interactors of SLAIN2, we
performed large-scale streptavidin pulldowns from
HEK293T::BirA*-SLAIN2 and HEK293T::BirA* cells.
To this end, the cells were incubated with 50 µM biotin
for 18 h and lysed by denaturing lysis buffer to solubilize
the centrosome. Biotinylated proteins were pulled down
by streptavidin chromatography and analyzed by mass
spectrometry. HEK293T cells stably expressing BirA* itself
was processed in parallel as a control. We analyzed the mass
spectrometry data from three experimental replicates for
BirA*-SLAIN2 and seven experimental replicates for BirA*
by using a label-free quantitative proteomics approach
termed normalized spectral abundance factor (NSAF)
(Zybailov et al., 2006). For NSAF analysis, we accounted
for run-to-run variation by comparing spectral counts
of each identified protein with the total spectral count of
the run. Of note, we did not normalize the data with the
length of identified proteins. After filtering out nonspecific
proteins based on comparative analysis of SLAIN2 datasets
with control datasets (>2.5 fold enrichment) and common
mass spectrometry contaminants, we identified 167 highconfidence proximity interactions for BirA*-SLAIN2.
The top 50 proximity interactors for SLAIN2 are
listed in Figure 3B. The SLAIN2 proximity interactome
includes the components of the SLAIN2 complex at the
microtubule plus-ends including CLASP1/2, EB1/2, and
CKAP5 (van der Vaart et al., 2011). Additionally, we
compared the SLAIN2 proximity interactome with the
list of putative SLAIN2 interactors that we derived from

BioGRID, a curated repository for protein interaction
datasets that includes mass spectrometry data generated
by affinity purification, yeast two hybrid screen, and
proximity labeling approaches (Stark et al., 2006). This
comparison identified CKAP5, SH3KBP1, CEP170,
CEP128, CNTRL, PCM1, TACC3, TACC2, CEP131,
MAPRE1, and MAPRE2 as the shared interactors, which
identifies them as high confidence SLAIN2 interactors.
Importantly, 156 interactions were specific to SLAIN2
proximity interactome.
For a more global and quantitative analysis of the SLAIN2
proximity interactome, we performed gene ontology (GO)
analysis for the top 100 proximity interactors of SLAIN2
based on cellular compartment, molecular function, and
biological process. GO analysis for cellular compartment
identified “centrosome”, “microtubule cytoskeleton”, and
“spindle” as highly enriched compartments, which is in
agreement with localization of SLAIN2 to the centrosome
and microtubules (Figure 3C). GO analysis showed that
in molecular function terms, the upregulated functions
were highly enriched in “microtubule plus-end binding”,
“cadherin binding”, and “dynein complex binding” (Figure
3D). While the association with microtubules and dynein
is in agreement with its reported microtubule-associated
functions, its proximity to cadherin-binding proteins
suggests possible functions for SLAIN2 in cell adhesion.
Interestingly, “RNA binding”, “gamma-tubulin binding”,
“protein kinase binding”, “SH3/SH2 adaptor activity”,
and “ubiquiting-dependent protein binding” were also
enriched in the interactome. Finally, in biological terms,
“regulation of cell cycle”, “cilium assembly” and “regulation
of intracellular transport” were highly enriched (Figure
3E). In order to reveal the interactions between the
proximity interactors of SLAIN2, we organized the top 100
proximity interactors into a protein interaction network
using the STRING database (Figure S2). This interaction
network revealed “centrosomes” and “microtubules” as the
main hubs.
3.4. SLAIN2 has extensive interactions with centrosome
and microtubule-associated proteins
To gain further insight into the functions of SLAIN2 at
the centrosome, we mined the group of novel SLAIN2
interactors and manually created a list of highly abundant
SLAIN2 interactors with well-defined functions in
previous studies. Among the new SLAIN2 interactors,
multiple clusters stand out by their functions in key
cellular processes associated with centrosomes, cilia, and
microtubules. We manually organized these proteins
according to their previously described functions and
generated a network map of SLAIN2 using Cytoscape
(Figure 4). Moreover, we generated a protein interaction
network among these proteins using the STRING database
(Figure S3). Proteins that were previously defined by their
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Figure 3. Localization, activity and proximity interactors of BirA*-SLAIN2. (A) HEK293T cells stably expressing BirA-SLAIN2 were
incubated with 50 µM biotin for 18 h, fixed and stained for V5-BirA*-SLAIN2 with V5 antibody, biotinylated proteins with fluorescent
streptavidin and centrosomes with anti-gamma-tubulin antibody. Scale bars represent 10 μm. Insets show 4× enlarged centrosomes.
(B) Mass spectrometry analysis of proximity interactors of BirA*-SLAIN2. The top 50 proximity interactors are ranked in the order
of their spectral counts normalized to the total spectral count of each mass spectrometry dataset generated from three experimental
replicates. Bolded proteins were previously shown to interact physically with SLAIN2. (C, D, E) Gene ontology analysis of the top 100
proximity interactors of SLAIN2 based on (C) cellular compartment, (D) molecular function, and (E) biological process. GO analysis
was performed using EnrichR. The bar graphs indicate the –log 10 of P-values for the indicated GO terms.
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localization and functions at the microtubule plus ends
were highly enriched in the SLAIN2 interactome, which is
in agreement with the well-characterized +TIP localization
of SLAIN2 (Akhmanova and Steinmetz, 2008; Akhmanova
and Steinmetz, 2010). Strikingly, CKAP5 was the most
abundant +TIP protein in the proximity map, even more
abundant than SLAIN2 itself. Given that BioID-mediated
biotinylation is proximity-dependent, the identification of
CKAP5 as the top prey suggests a stable and/or long-lived
interaction between CKAP5 and SLAIN2. In addition
to +TIPs, SLAIN2 have highly abundant proximity
interactions to other microtubule-associated proteins
(MAPs), including microtubule minus-end-binding
proteins CAMSAPs (Jiang et al., 2014).
Another cluster that stood out in SLAIN2 proximity
maps is the group of centrosome and centriolar satellite
proteins. Consistent with our characterization of SLAIN2
as a component of the pericentriolar material, SLAIN2
interacts with a wide range of pericentriolar material
proteins that were previously identified as regulators of
centriole duplication and mitosis. Moreover, SLAIN2 has
proximity interactions with a group of centriolar satellite
proteins including PCM1, AZI1/CEP131, and OFD1,
which is consistent with biotinylation of satellites in a
subset of BirA*-SLAIN2-expressing cells and suggests
functions for SLAIN2 during cilium assembly (Odabasi
et al., 2019; Prosser and Pelletier, 2020). Finally, a subset
of subdistal appendage proteins such as NIN and CEP128
were identified in SLAIN2 proximity maps (Uzbekov
and Alieva, 2018). Notably, NIN was among the first five
proximity interactors of SLAIN2. Given the function
of subdistal appendages in anchoring microtubules at
the centrosome, this relationship suggests centrosomal
functions for SLAIN2 in organization of microtubules.
4. Discussion
SLAIN2 is a microtubule plus-end tracking protein
implicated in cancer. Here we used the BioID approach
to generate the first in vivo proximity map of SLAIN2.
Our results provide new insight into the functions and
mechanisms of SLAIN2 through identification of its
proximity to previously characterized proteins and
complexes at the centrosomes and microtubules. Of
note, our results identify SLAIN2 as a dual regulator
of centrosome- and microtubule associated functions
and show that SLAIN2 mediates its functions in a more
complex mechanism than the one proposed by previous
studies.
The proximity interactome of SLAIN2 included most
known physical interactions at the microtubule tips
reported by previous studies (Akhmanova and Steinmetz,
2010). Interestingly, 50 of the putative SLAIN2 interactors
curated from the BioGRID database was not identified

in the SLAIN2 interactome. This could be in part due
to the differences in the nature of interactions revealed
by proximity-mapping, affinity purifications and yeast
two hybrid experiments or due to the interference of the
N-terminal BirA*-tag between SLAIN2 and a subset of its
interactors such as ch-TOG. In fact, a direct comparison
of affinity purifications and proximity mapping showed
that these two approaches identify both overlapping
and distinct interactions and thus should be used as
complementary approaches to define the complete set of
interactors for proteins of interest (Lambert et al., 2014).
A striking feature of the SLAIN2 proximity map is
that it is highly enriched for well-characterized centrosome
proteins. This is in agreement with our identification of
SLAIN2 as a bona fide centrosome protein that localizes
to the proximal end of centrioles. We note that despite our
identification of SLAIN2 at the centrosomes of mitotic
cells, a previous study showed that SLAIN2 loses its
association with microtubules upon phosphorylation in
mitosis (van der Vaart et al., 2011). Among the centrosome
proteins proximate to SLAIN2, several functional modules
stand out by their link to cellular processes that go awry
in cancer. Centriole duplication is a highly regulated
process that ensures duplication of centrioles once during
cell cycle. CEP152, CEP192, and CEP85 function in
initiation of centriole duplication by regulating centriolar
recruitment of the kinase PLK4 (Nigg and Holland, 2018).
CEP97 and CCP110 cap the distal ends of centrioles and
regulate centriole length (Spektor et al., 2007; Schmidt et
al., 2009). Deregulation of centriole duplication and length
results in supernumerary centrioles, which is a hallmark
for cancer and thus this mechanism might explain the
link between SLAIN2 and cancer (Nigg and Raff, 2009;
Godinho et al., 2014; Marteil et al., 2018;). In addition to
centriole duplication, centriolar satellites proteins are also
abundant in the SLAIN2 proximity interactome (Prosser
and Pelletier 2020). Among these proteins are PCM1,
CEP290, CSPP1, AZI1/CEP131, and OFD1, which are
well-characterized as key regulators of primary cilium
assembly and function (Firat-Karalar, 2018; Prosser and
Pelletier, 2020). Finally, consistent with the identification
of SLAIN2 as a component of pericentriolar material
by high-resolution imaging, SLAIN2 has proximity
interactions with pericentriolar material proteins such
as CEP55 and SPAG5 that function in cell division,
and PCNT, CDK5RAP2, and CEP250 that regulate
pericentriolar material organization. Future studies are
required to define the specific centrosomal functions of
SLAIN2.
The detection of an interactor by BioID-mediated
biotinylation correlates with its proximity to the BirA*fusion protein, the time spent in the vicinity of the
BirA*-fusion protein and its cellular abundance. Given
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Figure 4. SLAIN2 proximity interaction map at the centrosome and microtubules. The proximity interaction map of SLAIN2 was
constructed with selected proteins from mass spectrometry analysis using the Cytoscape software. The edges are color-coded according
to their function and localization. The magenta edges with green periphery represent the proximity interactors of SLAIN2 that were
also identified as physical interactors by previous studies. MAP: microtubule-associated protein, +TIP: microtubule plus-end binding
protein.

that we performed BioID pulldowns in cells stably
expressing BirA*-SLAIN2 fusions, the resulting proximity
interactome is a good resource for predicting the potential
direct interactors of SLAIN2 as well as the transient ones.
We predict that the top proximity interactors identified in
the SLAIN2 dataset are likely its direct interactors, which
is supported by the identification of +TIPs including
CKAP5, TACC1/2/3, and CLASP1 among the top 10
interactors. In addition to +TIPs, centriolar satellite
(PCM1, CEP131), subdistal appendage (NIN, CEP170),
and pericentriolar material proteins (ALMS1) are also
among this highly abundant group, suggesting functions
for SLAIN2 at these subcentrosomal domains. Although
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the relative abundance of preys is a good starting point for
predicting the functionally relevant SLAIN2 interactors,
we note that they should not be used alone since a subset of
critical interactions might be missed due to their transient
and low abundance nature.
The in vivo SLAIN2 proximity interactome we generated
provides a powerful resource for future studies aimed
at dissecting SLAIN2 functions and mechanisms at the
centrosome. An important first step to investigate these
functions is the confirmation of the putative SLAIN2
interactions using a set of different approaches. To assay
which proximity interactions are reflected at the physical level,
coimmunoprecipitation experiments can be used. However,

FIRAT-KARALAR / Turk J Biol
given the nature of the proximity labeling approach, the set of
insoluble and/or transient interactions will not be confirmed
by this conventional method. A good alternative to overcome
the limitations of conventional methods is the proximity
ligation assay, which allows in situ visualization of proteins
within 30 nm of each other (Bagchi et al., 2015). Once the
SLAIN2 interactions are validated, testable hypothesis about
its functions could be generated and tested in subsequent
loss-of-function and gain-of-function experiments.
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Figure S1. Subcentrosomal localization of SLAIN2 relative to CEP152 and centrin. U2OS cells were fixed and stained with the
indicated antibodies and images were acquired with Leica SP8 Hyvolution confocal. Intensity plots of SLAIN2, myc-CEP152, and
centrin for the top-view are generated by the “Plot Profile” tool in ImageJ. Scale bar 0.5 µm.
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Figure S2. STRING interaction network for the top 100 proximity interactors of SLAIN2. Known and predicted interactions between
the top 100 proximity interactors of SLAIN2 according to the STRING database.
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Figure S3. STRING interaction network for the proximity interactors of SLAIN2 implicated in centrosome- and microtubuleassociated functions. Known and predicted interactions between the selected proximity interactors of SLAIN2 according to the
STRING database.
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